These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1300179)

  • 1. Myoblast transfer in muscular dystrophy: panacea or pie in the sky?
    Dubowitz V
    Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited review: myoblast transfer: a possible therapy for inherited myopathies?
    Partridge TA
    Muscle Nerve; 1991 Mar; 14(3):197-212. PubMed ID: 2041542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the xmd dog in the assessment of myoblast transfer therapy.
    Cooper BJ
    Adv Exp Med Biol; 1990; 280():279-82; discussion 282-4. PubMed ID: 2248148
    [No Abstract]   [Full Text] [Related]  

  • 4. The principles and practice of myoblast transfer.
    Karpati G
    Adv Exp Med Biol; 1990; 280():69-74. PubMed ID: 2248156
    [No Abstract]   [Full Text] [Related]  

  • 5. Myoblast transplantation in inherited myopathies.
    Morgan JE; Watt DJ
    Mol Cell Biol Hum Dis Ser; 1993; 3():303-31. PubMed ID: 8111544
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on the present state of knowledge for myoblast transfer therapy.
    Grounds MD
    Cell Transplant; 1996; 5(3):431-3. PubMed ID: 8727012
    [No Abstract]   [Full Text] [Related]  

  • 7. Plausible structural/functional/behavioral/biochemical transformations following myoblast transfer therapy.
    Law PK; Goodwin TG; Li HJ; Chen M
    Adv Exp Med Biol; 1990; 280():241-9; discussion 249-50. PubMed ID: 2248145
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular markers for myoblast transplantation in GRMD.
    Bartlett RJ; Sharp NJ; Hung WY; Kornegay JN; Roses AD
    Adv Exp Med Biol; 1990; 280():273-8. PubMed ID: 1978966
    [No Abstract]   [Full Text] [Related]  

  • 9. Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy.
    Huard J; Bouchard JP; Roy R; Labrecque C; Dansereau G; Lemieux B; Tremblay JP
    Clin Sci (Lond); 1991 Aug; 81(2):287-8. PubMed ID: 1653675
    [No Abstract]   [Full Text] [Related]  

  • 10. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions.
    Huard J; Roy R; Bouchard JP; Malouin F; Richards CL; Tremblay JP
    Transplant Proc; 1992 Dec; 24(6):3049-51. PubMed ID: 1466052
    [No Abstract]   [Full Text] [Related]  

  • 11. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.
    Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM
    Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical aspects of myoblast implantation: investigations on two inherited myopathies in animals.
    Morgan JE
    Adv Exp Med Biol; 1990; 280():89-94; discussion 95-6. PubMed ID: 2248159
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoblast transfer in Duchenne muscular dystrophy.
    Karpati G; Ajdukovic D; Arnold D; Gledhill RB; Guttmann R; Holland P; Koch PA; Shoubridge E; Spence D; Vanasse M
    Ann Neurol; 1993 Jul; 34(1):8-17. PubMed ID: 8517684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dilemma of manifesting carriers in the context of myoblast transplantation.
    Kunkel LM
    Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of pre-mRNA splicing in the Duchenne muscular dystrophy gene.
    Dunckley MG; Eperon IC; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):276S. PubMed ID: 8736934
    [No Abstract]   [Full Text] [Related]  

  • 17. Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987.
    Hoffman EP; Brown RH; Kunkel LM
    Biotechnology; 1992; 24():457-66. PubMed ID: 1422053
    [No Abstract]   [Full Text] [Related]  

  • 18. Xenotransplantation of embryonic precursors of human myogenesis for the correction of dystrophinopathy in mice with hereditary muscular dystrophy.
    Yarygin VN; Sukhikh GT; Sitnikov VF; Stenina MA; Kuznetsov AB; Poltavtseva RA; Krivov LI; Voevodin DA; Savchuk VI; Revishchin AV; Korochkin LI; Aleksandrova MA
    Bull Exp Biol Med; 2003 Jul; 136(1):88-92. PubMed ID: 14534620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferring myoblasts in Duchenne dystrophy.
    Dubowitz V
    BMJ; 1992 Oct; 305(6858):844-5. PubMed ID: 1422391
    [No Abstract]   [Full Text] [Related]  

  • 20. The physiological evaluation of gene therapies of dystrophin-deficient muscles.
    Gillis JM; Deconinck N
    Adv Exp Med Biol; 1998; 453():411-6; discussion 417. PubMed ID: 9889852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.